New cutting edge technology can be used to grade cancer tumours, eradicating human subjectivity and ensuring patients get the right treatment.
A new imaging technology to grade tumour biopsies has been developed by a team of scientists led by the Department of Physics and the Department of Surgery and Cancer at Imperial College London.
Publishing their results today in the journal Convergent Science Physical Oncology, they describe how their new method promises to significantly reduce the subjectivity and variability in grading the severity of cancers.
[Digistain] is an extremely reliable indicator of the degree of progression of the disease. Because it is based on a physical measurement, rather than a human judgement, it promises to remove the element of chance in cancer diagnosis.Professor Chris Phillips
Nearly all cancers are still diagnosed by doctors taking a sample of the tumour, a so-called biopsy, then slicing it thinly and staining it with two vegetable dyes used for more than 100 years. They look at this ‘H+E stained’ sample under a microscope and then judge the severity of the disease by eye alone.
Life-changing treatment decisions have to be based on this ‘grading’ process, yet it is well known that different practitioners given the same slice will only agree on its grade about 70% of the time, resulting in an overtreatment problem.
The team’s new ‘Digistain’ technology addresses this problem by using invisible mid-infrared light to photograph the tissue slices in a way that maps out the chemical changes that signal the onset of cancer. In particular, they measure the ‘nuclear-to-cytoplasmic-ratio’ (NCR): a recognized biological marker for a wide range of cancers.
Lead author Professor Chris Phillips, from the Department of Physics at Imperial, said: “Our machine gives a quantitative ‘Digistain index’ (DI) score, corresponding to the NCR, and this study shows that it is an extremely reliable indicator of the degree of progression of the disease. Because it is based on a physical measurement, rather than a human judgement, it promises to remove the element of chance in cancer diagnosis. “
Eliminating subjectivity
In the experiment reported today, the team carried out a double-blind clinical pilot trial using two adjacent slices taken from 75 breast cancer biopsies. The first slice was graded by clinicians as usual, using the standard H+E protocol. It was also used to identify the so-called ‘region of interest’ (RoI), i.e. the part of the slice containing the tumour.
The team then used the Digistain imager to get a DI value averaged over the corresponding RoI on the other, unstained slice, and ran a statistical analysis on the results.
Professor Phillips said: “Even with this modest number of samples, the correlation we saw between the DI score and the H+E grade would only happen by chance 1 time in 1400 trials. The strength of this correlation makes us extremely optimistic that Digistain will be able to eliminate subjectivity and variability in biopsy grading.”
Proving its worth
The NCR factor that Digistain measures is known to be common to a wide range of cancers, as it occurs when the reproductive cell cycle gets disrupted in the tumour and cell nuclei get distorted with rogue DNA. It is likely that in the long run, Digistain could help with the diagnosis of all different types of cancer.
At a practical level, the researchers say that the Digistain imaging technology can easily and cheaply be incorporated into existing hospital labs, and be used by their staff. Professor Philips added: “It’s easy to prove its worth by checking it with the thousands of existing biopsy specimens that are already held in hospital archives. Together these facts will smooth the path into the clinic, and it could be saving lives in only a couple of years.”
Learn more: ‘Digistain’ technology offers revolution in detailed cancer diagnosis
The Latest on: Cancer diagnosis
[google_news title=”” keyword=”cancer diagnosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer diagnosis
- Doctors said it was growing pains - but it turned out to be cancer: Agony of 11-year-old girl diagnosed with rare bone tumour that left her fearing she would dieon May 9, 2024 at 3:26 am
A schoolgirl who thought she had standard ‘growing pains’ ended up being diagnosed with cancer. Ivie Adams, 11, feared she would die after heartbreakingly being told that she had a 26cm tumour growing ...
- Somerset man wins £65k dream car two weeks after cancer diagnosison May 9, 2024 at 3:24 am
A Somerset man who was diagnosed with cancer has won his dream car worth nearly £65,000 just two weeks after the heartbreaking news. Chris Turner, from Bridgwater, was on his way to get more scans ...
- Girl, 11, diagnosed with rare bone cancer initially dismissed as 'growing pains'on May 9, 2024 at 3:07 am
A schoolgirl underwent life-saving surgery to stop a rare bone cancer which was originally put down to growing pains. Ivie Adams, 11, was diagnosed with malignant peripheral nerve sheath tumour - a ...
- Pregnant with pancreatic cancer: How a NJ mom endures a devastating diagnosison May 9, 2024 at 1:31 am
Months before she was due to give birth to her second daughter last year, Jaclyn Lin was eventually diagnosed with stage 4 pancreatic cancer.
- I Had Cancer. My Treatment Was Eye-Opening About Addictionon May 9, 2024 at 1:30 am
I'm a white, middle-class, well-insured man who has worked in non-profit behavioral health services for more than 30 years, so my social determinants of health are admittedly different to others I met ...
- 'Game of Thrones' actor Ian Gelder dies months after cancer diagnosison May 8, 2024 at 6:28 pm
LONDON, UK — Actor Ian Gelder, known for playing Kevan Lannister on the popular HBO series "Game of Thrones," has died at age 74, five months after a cancer diagnosis. His husband, actor Ben Daniels, ...
- EastEnders star Cheryl Fergison on why she "kept quiet" on cancer diagnosison May 8, 2024 at 3:31 pm
EastEnders actor Cheryl Fergison has opened up about why she "kept quiet" about her cancer diagnosis. Cheryl, who played Heather Trott in the BBC One soap between 2007 and 2012, was told she had Stage ...
- Prince Harry Has Been Allegedly Doing This for Kate Middleton Amid Cancer Diagnosis, Sources Claimon May 8, 2024 at 2:00 pm
Despite so many inside sources and insiders claiming Catherine, Princess of Wales, better known as Kate Middleton, and Prince Harry are at odds. We all know that there’s an alleged, ongoing feud ...
- EastEnders star Cheryl Fergison reveals heartbreaking condition she developed following cancer diagnosison May 8, 2024 at 9:26 am
Cheryl Fergison appeared on Loose Women to discuss how her cancer diagnosis led to her experiencing obsessive compulsive disorder ...
via Bing News